Posttranscriptional regulation of acute phase serum amyloid A2 expression by the 5'- and 3'-untranslated-regions of its mRNA

Journal of Immunology

Volumn 163, Issue 8, 1999, Pages 4537-4545

  Longley, Daniel B ^a,c   Steel, Diana M ^a,d   Whitehead, Alexander S ^b  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^d Foley Hoag and Eliot LLP ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; AMYLOID A PROTEIN; AMYLOID A2; INTERLEUKIN 1; INTERLEUKIN 6; MESSENGER RNA; UNCLASSIFIED DRUG;

ACUTE PHASE RESPONSE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HOST RESISTANCE; HUMAN; HUMAN CELL; INFLAMMATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEIN SYNTHESIS; RNA ANALYSIS; RNA TRANSLATION; TRANSCRIPTION REGULATION;

EID: 0032851599     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Steel, D. M., and A. S. Whitehead. 1994. The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein. Immunol. Today 15:81.
2. Kushner, I. 1982. The phenomenon of the acute phase response. Ann. NY Acad. Sci. 389:39.
3. Whitehead, A. S., M. C. de Beer, D. M. Steel, M. Rits, J. M. Lelias, W. S. Lane, and F. C. de Beer. 1992. Identification of novel members of the serum amyloid A protein superfamily as constitutive apolipoproteins of high density lipoprotein. J. Biol. Chem. 267:3862.
4. Kluve-Beckerman, B., G. L. Long, and M. D. Benson. 1986. DNA sequence evidence for polymorphic forms of human serum amyloid A (SAA). Biochem. Genet. 24:795.
5. Marhaug, G. 1983. Three assays for the characterization and quantitation of human serum amyloid A. Scand. J. Immunol. 18:329.
6. Uhlar, C. M., C. J. Burgess, P. M. Sharp, and A. S. Whitehead. 1994. Evolution of the serum amyloid A (SAA) protein superfamily. Genomics 19:228.
7. Steel, D. M., G. C. Sellar, C. M. Uhlar, S. Simon, F. C. DeBeer, and A. S. Whitehead. 1993. A constitutively expressed serum amyloid A protein gene (SAA4) is closely linked to, and shares structural similarities with, an acute-phase serum amyloid A protein gene (SAA2). Genomics 16:447.
8. Sellar, G. C., and A. S. Whitehead. 1993. Localization of four human serum amyloid A (SAA) protein superfamily genes to chromosome 11p: characterization of a fifth SAA-related gene sequence. Genomics 16:774.
9. Kluve-Beckerman, B., M. L. Drumm, and M. D. Benson. 1991. Nonexpression of the serum amyloid A three (SAA3) gene. DNA Cell Biol. 10:651.
10. Sellar, G. C., S. A. Jordan, W. A. Bickmore, J. A. Fantes, V. van Heyningen, and A. S. Whitehead. 1994. The human serum amyloid A protein (SAA) superfamily gene cluster: mapping to chromosome 11p15.1 by physical and genetic linkage analysis. Genomics 19:221.
11. Hoffman, J. S., and E. P. Benditt. 1982. Changes in high density lipoprotein content following endotoxin administration in the mouse: formation of serum amyloid protein-rich subfractions. J. Biol. Chem. 257:10510.
12. Marhaug, G., K. Sletten, and G. Husby. 1982. Characterization of amyloid related protein SAA complexed with serum lipoproteins (apoSAA). Clin. Exp. Immunol. 50:382.
13. Pruzanski, W., F. C. de Beer, M. C. de Beer, E. Stefanski, and P. Vadas. 1995. Serum amyloid A protein enhances the activity of secretory non-pancreatic phospholipase A2. Biochem. J. 309:461.
14. Kisilevsky, R., and L. Subrahmanyan. 1992. Serum amyloid A changes high density lipoprotein's cellular affinity: a clue to serum amyloid A's principal function [published erratum appears in 1992, Lab. Invest. 67:151]. Lab. Invest. 66:778.
15. + cells. J. Immunol. 156:1189.
16. Xu, L., R. Badolato, W. J. Murphy, D. L. Longo, M. Anver, S. Hale, J. J. Oppenheim, and J. M. Wang. 1995. A novel biological function of serum amyloid A: induction of T lymphocyte migration and adhesion. J. Immunol. 155:1184.
17. Badolato, R., J. M. Wang, W. J. Murphy, A. R. Lloyd, D. F. Michiel, L. L. Bausserman, D. J. Kelvin, and J. J. Oppenheim. 1994. Serum amyloid A is a chemoattractant: induction of migration, adhesion, and tissue infiltration of monocytes and polymorphonuclear leukocytes. J. Exp. Med. 180:203.
18. Husebekk, A., B. Skogen, G. Husby, and G. Marhaug. 1985. Transformation of amyloid precursor SAA to protein AA and incorporation in amyloid fibrils in vivo. Scand. J. Immunol. 21:283.
19. Tape, C., R. Tan, M. Nesheim, and R. Kisilevsky. 1988. Direct evidence for circulating apoSAA as the precursor of tissue AA amyloid deposits. Scand. J. Immunol. 28:317.
20. Steinmetz, A., G. Hocke, R. Saile, P. Puchois, and J. C. Fruchart. 1989. Influence of serum amyloid A on cholesterol esterification in human plasma. Biochim. Biophys. Acta 1006:173.
21. Ross, R. 1993. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362:801.
22. Steel, D. M., and A. S. Whitehead. 1991. Heterogeneous modulation of acute-phase-reactant mRNA levels by interleukin-1β and interleukin-6 in the human hepatoma cell line PLC/PRR5 [published erratum appears in Biochem. J. 281: 879]. Biochem. J. 277:477.
23. Steel, D. M., J. T. Rogers, M. C. DeBeer, F. C. DeBeer, and A. S. Whitehead. 1993. Biosynthesis of human acute-phase serum amyloid A protein (A-SAA) in vitro: the roles of mRNA accumulation, poly(A) tail shortening and translational efficiency. Biochem. J. 291:701.
24. Uhlar, C. M., S. Grehan, D. M. Steel, A. Steinkasserer, and A. S. Whitehead. 1997. Use of the acute phase serum amyloid A2 (SAA2) gene promoter in the analysis of pro- and anti-inflammatory mediators: differential kinetics of SAA2 promoter induction by IL-1β and TNFα compared to IL-6. J. Immunol. Methods 203:123.
25. McCarthy, J. E., and H. Kollmus. 1995. Cytoplasmic mRNA-protein interactions in eukaryotic gene expression. Trends Biochem. Sci. 20:191.
26. Zahedi K., W. A. Gonnerman, F. C. DeBeer, M. C. DeBeer, D. M. Steel, J. D. Sipe, and A. S. Whitehead. 1991. Major acute-phase reactant synthesis during chronic inflammation in amyloid-susceptible and -resistant mouse strains. Inflammation 15:1.
27. Kunkel, T. A., J. D. Roberts, and R. A. Zakour. 1987. Rapid and efficient site-specific mutagenesis without phenotypic selection. Methods Enzymol. 154:367.
28. Auffray, C., and F. Rougeon. 1980. Purification of mouse immunoglobulin heavy-chain messenger RNAs from total myeloma tumor RNA. Eur. J Biochem. 107:303.
29. Kozak, M. 1987. An analysis of 5′-noncoding sequences from 699 vertebrate messenger RNAs. Nucleic Acids Res. 15:8125.
30. Kozak, M. 1986. Influences of mRNA secondary structure on initiation by eukaryotic ribosomes. Proc. Natl. Acad. Sci. USA 83:2850.
31. Kozak, M. 1989. Circumstances and mechanisms of inhibition of translation by secondary structure in eucaryotic mRNAs. Mol. Cell. Biol. 9:5134.
32. Baumann, H., and J. Gauldie. 1994. The acute phase response. Immunol. Today 15:74.
33. Jiang, S. L., G. Lozanski, D. Samols, and I. Kushner. 1995. Induction of human serum amyloid A in Hep3B cells by IL-6 and IL-1β involves both transcriptional and post-transcriptional mechanisms. J. Immunol. 154:825.
34. Ganter, U., R. Arcone, C. Toniatti, G. Morrone, and G. Ciliberto. 1989. Dual control of C-reactive protein gene expression by interleukin-1 and interleukin-6. EMBO J. 8:3773.
35. Gray, N. K., and M. W. Hentze. 1994. Iron regulatory protein prevents binding of the 43S translation pre-initiation complex to ferritin and eALAS mRNAs. EMBO J. 13:3882.
36. Diederich, M., M. el yaagoubi, P. Gerardin, M. Wellman, and G. Siest. 1995. Characterization and regulatory effect of γ-glutamyltransferase messenger RNA untranslated regions in human leukemia. Leukemia 9:1332.
37. Lozanski, G., S. L. Jiang, D. Samols, and I. Kushner. 1996. C-reactive protein and serum amyloid A mRNA stability following induction by cytokines. Cytokine 8:534.
38. Decker, C. J., and R. Parker. 1995. Diversity of cytoplasmic functions for the 3′ untranslated region of eukaryotic transcripts. Curr. Opin. Cell Biol. 7:386.
39. Binder, R., J. A. Horowitz, J. P. Basilion, D. M. Koeller, R. D. Klausner, and J. B. Harford. 1994. Evidence that the pathway of transferrin receptor mRNA degradation involves an endonucleolytic cleavage within the 3′-UTR and does not involve poly(A) tail shortening. EMBO J. 13:1969.
40. Nielson, F. C., and J. Christiansen. 1992. Endonucleolysis in the turnover of insulin-like growth factor II mRNA. J. Biol. Chem. 267:19404.